Medistim ASA Cash Flow Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	159.21	103.83	103.82	113.97	90.9
Depreciation & Amortization	16.02	24.51	23.66	23.29	23.43
Other Operating Activities	23.18	2.01	5.69	12.91	9.83
Change in Accounts Receivable	-	5.32	27.35	-33.02	-11.15
Change in Inventory	-	-15.13	-31.06	-16.92	15.25
Change in Accounts Payable	-	1.95	0.61	11.27	-0.32
Change in Other Net Operating Assets	-6.83	20.61	-10.88	2	-0.57
Operating Cash Flow	191.57	143.1	119.2	113.49	127.37
Operating Cash Flow Growth	33.87%	20.06%	5.03%	-10.90%	71.82%
Capital Expenditures	-	-6.07	-16.4	-9.25	-7.4
Sale (Purchase) of Intangibles	-	-18.63	-13.33	-11.85	-4.08
Other Investing Activities	-36	-	-	-	-
Investing Cash Flow	-36	-24.69	-29.73	-21.1	-11.49
Long-Term Debt Repaid	-8.81	-9.12	-8.71	-7.31	-12
Net Debt Issued (Repaid)	-8.81	-9.12	-8.71	-7.31	-12
Repurchase of Common Stock	-4.41	-	-	-	-
Common Dividends Paid	-109.47	-82.41	-82.18	-68.4	-54.64
Other Financing Activities	-	-	-	5.4	7.59
Financing Cash Flow	-122.69	-91.53	-90.89	-70.3	-59.05
Foreign Exchange Rate Adjustments	-	-1.54	2.65	1.07	0.76
Net Cash Flow	32.88	25.34	1.23	23.15	57.6
Free Cash Flow	191.57	137.04	102.8	104.24	119.97
Free Cash Flow Growth	39.80%	33.30%	-1.38%	-13.11%	79.91%
Free Cash Flow Margin	27.38%	24.64%	19.73%	21.44%	28.71%
Free Cash Flow Per Share	10.48	7.48	5.62	5.70	6.57
Cash Income Tax Paid	-	28.4	25.7	19.17	13.34
Levered Free Cash Flow	157.55	81.67	64.81	56.39	98.98
Unlevered Free Cash Flow	168.07	81.67	64.81	56.47	99.09
Change in Working Capital	-6.83	12.75	-13.97	-36.68	3.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.